This episode's focus is on Distribution Channels. In our takeaways we explore how Amazon is using some unconventional measures to increase capacity in their distribution channels, how drugmakers will need to overcome a multitude of obstacles when designing the supply chains that will eventually deliver a vaccine for COVID-19, and how research suggests that resiliency measures in the distribution channel might be a great investment. This episode also sees the return of the Supply Chain Bedtime Story where a disappointing experience at Home Depot can be linked back to poor distribution channel selection and a poor adaptation to market trends. 

Sources of Information for this Episode:

Amazon’s Reliance on Tents to Increase Capacity: https://www.supplychaindive.com/news/amazon-tents-logistics-delivery-footprint/552931/

Amazon’s Sales Increases During COVID: https://www.fool.com/investing/2020/05/05/heres-how-coronavirus-will-impact-amazons-profit-g.aspx

Drugmakers Race to Build New Supply Chains for Vaccines: https://www.wsj.com/articles/drugmakers-race-to-build-covid-19-vaccine-supply-chains-11596101586

Research from Bain & Company Suggests Resilience is a Good Investment: https://www.bain.com/insights/supply-chain-lessons-from-covid-19/

Industries that Millennials are Killing: https://www.businessinsider.com/millennials-are-killing-list-2017-8

Hosts: Justin Wilcox, CPIM & Marcus Bugni, CPIM

Editing: Marcus Bugni, CPIM

Music: Marcus Bugni, CPIM

Research & Content: Justin Wilcox, CPIM

--- Support this podcast: https://anchor.fm/thestrongestlinksc/support

---

Support this podcast: https://podcasters.spotify.com/pod/show/thestrongestlinksc/support